Encouraging adherence to long-term medication.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Medication management support in diabetes: a systematic assessment of diabetes self-management apps.BMC medicine · 2019
   Pooled it
2. Effect of a one time guideline based educational video intervention on osteoporosis related knowledge.Archives of orthopaedic and trauma surgery · 2026
   Trial
3. Prioritising medication management criteria to identify emergency department patients with potential medication-related harm: Nominal Group Technique workshops with clinicians.International journal of clinical pharmacy · 2026
   Article
4. Osteoporosis-related knowledge in a German adult population: determinants and translational implications for fragility fracture prevention.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
   Article
5. Yushida: an IoT-based smart injection system for long-term management of chronic diseases.Frontiers in digital health · 2026
   Review
6. A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.Frontiers in immunology · 2026
   Article
7. Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach.JMIR cancer · 2024
   Article
8. Therapeutic inertia.Australian prescriber · 2024
   Review
9. Dishing out the meds.The British journal of cardiology · 2024
   Article
10. The Use of Gamification in the Self-Management of Patients With Chronic Diseases: Scoping Review.JMIR serious games · 2023
    Article
11. Improving health literacy of antibiotic use in people with cystic fibrosis (CF)-comparison of the readability of patient information leaflets (PILs) from the EU, USA and UK of 23 CF-related antibiotics used in the treatment of CF respiratory infections.JAC-antimicrobial resistance · 2023
    Article
12. Direct and Indirect Predictors of Medication Adherence With Bipolar Disorder: Path Analysis.JMIR formative research · 2023
    Article
13. Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan.Frontiers in public health · 2023
    Review
14. Implementation of the Patient Counselling Service at the Cancer Hospital in Radom, Poland.International journal of environmental research and public health · 2022
    Article
15. Guidelines not for everyone.Australian prescriber · 2022
    Article
16. Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews.JMIR cancer · 2022
    Review
17. The Use of Gamification and Incentives in Mobile Health Apps to Improve Medication Adherence: Scoping Review.JMIR mHealth and uHealth · 2022
    Article
18. Follow-up loss in smoking cessation consultation: can we predict and prevent it?Journal of thoracic disease · 2021
    Article
19. Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis.BMC neurology · 2021
    Observational
20. Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.Frontiers in pharmacology · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as